(Q43884681)

27 November 2017

title

Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population (English)

1 reference

chronic obstructive pulmonary disease

27 November 2017

main subject

1 reference

Manan Shah

2

1 reference

27 November 2017

Pallavi Rane

4

1 reference

27 November 2017

Anand A. Dalal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854113

16 July 2024

Anna O. D'Souza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854113

16 July 2024

language of work or name

English

0 references

publication date

20 September 2010

1 reference

full work available at URL

27 November 2017

https://www.tandfonline.com/doi/pdf/10.3111/13696998.2010.521734?needAccess=true

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854113

http://www.informapharmascience.com/doi/abs/10.3111/13696998.2010.521734

16 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854113

http://www.tandfonline.com/doi/pdf/10.3111/13696998.2010.521734

16 July 2024

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Journal of Medical Economics

16 July 2024

published in

1 reference

27 November 2017

volume

13

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

591-598

1 reference

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.

16 July 2024

2

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients: new insights

16 July 2024

4

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population

16 July 2024

5

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Capitation, managed care, and chronic obstructive pulmonary disease

16 July 2024

6

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization

16 July 2024

7

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature

16 July 2024

8

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

The burden of COPD in the U.S.A.: results from the Confronting COPD survey

16 July 2024

9

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Pharmacoeconomic evaluation of COPD.

16 July 2024

10

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective

16 July 2024

11

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data

16 July 2024

12

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

16 July 2024

13

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

The costs of treating COPD in the United States

16 July 2024

14

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

16 July 2024

15

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

16 July 2024

16

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Cost of Chronic Obstructive Pulmonary Disease in the Emergency Department and Hospital: An Analysis of Administrative Data from 218 US Hospitals

16 July 2024

17

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.

16 July 2024

18

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

16 July 2024

19

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

16 July 2024

20

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients

16 July 2024

21

1 reference

https://api.crossref.org/works/10.3111/13696998.2010.521734

16 July 2024

Identifiers

1 reference

27 November 2017

1 reference